Eli Lilly (LLY) sees Significant Insider Selling Continuing

Thursday, October 05, 2017 10:15 PM ET

Eli Lilly (LLY) sees Significant Insider Selling Continuing

A filing with the SEC today revealed a significant insider sale of Eli Lilly shares as — Lilly Endowment Inc, 10% Owner — sold 205,000 shares in the company having a market value of approximately $17,795,025. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 785,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 990,000 shares and have averaged 495,000 shares per transaction over this time period.

Eli Lilly insider trading represents a level of buy/sell trades that is above for the 115 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 115 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Eli Lilly insiders was also higher. Within the peer group there were 2,829,099 shares purchased and 5,151,667 shares sold with company insiders disposing of 20,196 shares on average.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data obtained to compose and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.